3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
2
Terminated
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Thyroid Nodule
1
Respiratory Sounds
1
Prostatic Neoplasms
1
Lymphoma, Follicular
1
Infections
1
Glioblastoma
1
Brain Neoplasms
1
Astrocytoma
1
Asthma
1
Interventions
Voriconazole
4
Vancomycin
3
Fluconazole
3
Filgrastim
3
Ciprofloxacin
3
Caspofungin
3
liposomal amphotericin B
2
Trimethoprim, Sulfamethoxazole Drug Combination
2
Therapeutics
2
Piperacillin, Tazobactam Drug Combination
2
Peripheral Blood Stem Cell Transplantation
2
Melphalan
2
Itraconazole
2
Granulocyte Colony-Stimulating Factor
2
Fosfomycin
2
Daptomycin
2
Cyclophosphamide
2
Cefazolin
2
Antibiotic Prophylaxis
2
ziprasidone
1
threonic acid
1
telavancin
1
soybean oil, phospholipid emulsion
1
plerixafor
1
monalizumab
1
lime
1
human papillomavirus vaccine, L1 type 16, 18
1
fluorescein isothiocyanate-keyhole limpet hemocyanin
1
fludarabine phosphate
1
fish oil triglycerides
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Infections
×
Amoxicillin-Potassium Clavulanate Combination
×
Clear all
NCT03228108
2022-05-10
pro-SWAP
Radboud University Medical Center
Phase 4
Completed
1,538 enrolled